Search Results For :: Potato protein
-
Agrochemicals Market by Type (Fertilizers, Pesticides), Crop Type (Cerelas & Grains, Oilseeds & Pulses, Fruits & Vegetables), Fertilizers Type, Pesticide Type (Insecticides, Herbicides, Fungicides, Nematicides) and Region - Global Forecast to 2028
The global agrochemicals market is projected to reach USD 282.2 billion by 2028, recording a CAGR of 3.7% during the forecast period. The key players in this market include UPL (India), Nufarm (Australia), ADAMA (Israel), Bayer AG (Germany),
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Pet Food Ingredients Market Size, Share, Industry Growth Trends Report by Ingredient (Meat & Meat Products Cereals, Vegetables & Fruits Fats, and Additives), Source (Animal-Based, Plant Derivatives, & Synthetic), Pet (Dogs, Cats, and Fish), Form, and Region - Global Forecast to 2028
According to MarketsandMarkets, the pet food ingredients market size is projected to reach USD 47.4 billion by 2028, at a CAGR of 6.8% during the forecast period. Key players in this market include BASF SE (Germany), Darling Ingredients Inc (US), Cargill, Incorporated (US), Ingredion (US), DSM (Netherlands), Omega Protein Corporation (US), ADM (US), Kemin Industries, Inc (US), Chr. Hansen Holding A/S (Denmark), Roquette Frères (France), The Scoular Company (US), Symrise (Germany), Mowi (Norway), Lallemand Inc. (Canada), and Phileo by Lesaffre (France). Other noticeable players also include 3D Corporate Solutions (US), Hydrite Chemical (US), AFB International (US), Gillco Ingredients (US), SARIA International GmbH (Germany), Green Source Organics (US), Biorigin (Brazil), Zinpro (US), APS Phoenix LLC (US), LaBudde Group Inc (US), FoodSafe Technologies (US), DuPont Nutrition & Health (US), and Eurotec Nutrition Group (Thailand).
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), Enduser, and Region - Global Forecast to 2032
The global cancer biomarkers market is projected to reach USD 54.48 billion by 2032, growing at a CAGR of 11.6% during the forecast period (2026–2032). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 7150
- TOC Available:
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024
The leukemia therapeutics market is projected to reach USD 17.1 billion by 2024, at a CAGR of 6.8%. Market growth is largely driven by the rising prevalence of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) and increasing approvals of novel & innovative drugs and immunotherapies. The major players in this market are AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland, F. Hoffmann-La Roche (Switzerland), Pfizer (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Takeda Pharmaceutical (Japan), and Celgene (US). Product approvals are a key strategy adopted by key players in order to enhance their dominance in this market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
Records 51 to 54 of 54
